FDA & Government News

ACOG Counters Federal Acetaminophen Concerns

Steven J. Fleischman, MD, MBA, FACOG, president of the American College of Obstetricians and Gynecologists released remarks on analgesic safety for patients who are pregnant.

Share

The American College of Obstetricians and Gynecologists (ACOG) has reaffirmed the safety of acetaminophen use during pregnancy amid concerns raised by the US Department of Health and Human Services regarding potential neurodevelopmental risks. ACOG president Dr. Steven J. Fleischman highlighted over 20 years of research, including significant cohort studies, demonstrating no link between prenatal acetaminophen exposure and conditions such as autism or ADHD. Despite some reviews suggesting otherwise through lower-quality evidence, ACOG insists on the medication's therapeutic necessity for managing pain and fever to prevent adverse outcomes for both the mother and fetus.

Original Source(s)

ACOG Counters Federal Acetaminophen Concerns

Steven J. Fleischman, MD, MBA, FACOG, president of the American College of Obstetricians and Gynecologists released remarks on analgesic safety for patients who are pregnant.

  • by Teraya Smith

  • September 23, 2025

  • 2 min

Related Content

Higher Gynecologic, Obstetric Risk in EDS

Female patients with Ehlers–Danlos syndromes have markedly higher rates of gynecologic, obstetric, and urogynecologic conditions, new research shows.

30 Minutes to Relief? Real-World Data Say Yes

Real-world patient-reported outcomes show high responder rates, favorable tolerability, and consistent satisfaction with hyoscine butylbromide plus for menstrual pain self-treatment.

HRSA Adds Self-Collection to Screening

Updated guidelines position patient-collected testing as an option for patients aged 30 to 65 years who are at average risk of cervical cancer, with mandatory insurance coverage beginning January 2027